Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in Switzerland

Andreas Klaus Pfeifer, Tine Gregersen, Henning Grønbæk, Carsten Palnæs Hansen, Jan Müller-Brand, Karin Herskind Bruun, Klaus Krogh, Andreas Kjær, Ulrich Knigge

    84 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in Switzerland'. Together they form a unique fingerprint.

    Medicine & Life Sciences